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Abstract: Among the major components of the Golgi apparatus are the GRASP family proteins, including GRASP65 on the cis-Golgi side. With 
its GRASP domain, GRASP65 is involved in Golgi stacking and ribbon formation. Interaction of GRASP65 with the Golgi marker protein GM130 
is important for the docking of vesicles to the Golgi membrane. We present here structures of the two individual PDZ domains comprising the 
GRASP domain in human GRASP65. We use isothermal titration calorimetry to probe the interaction between GRASP65 and GM130. 
Additionally, we present evidence for the limited sequence conservation of the PDZ fold by describing the PDZ domain structure of the GRASP65 
homolog Grh1 from Saccharomyces cerevisiae. 
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INTRODUCTION 
S part of the endomembrane system of eukaryotic 
cells, the Golgi apparatus is traversed by proteins 
originating from the endoplasmic reticulum (ER) as they 
translocate to their final destination in or beyond the 
plasma membrane. It is composed of cisternal membrane 
structures arranged in Golgi stacks which are further 
organized into a larger ribbon structure.[1] The Golgi 
apparatus has three primary compartments, known as “cis” 
(cisternae nearest the endoplasmic reticulum), “medial” 
(central layers of cisternae), and “trans” (cisternae farthest 
from the endoplasmic reticulum). The cis-Golgi network is 
the entry area at the convex side of the Golgi stack which 
faces to the ER whereas the trans-Golgi network is the 
concave side that directs newly synthesized proteins to 
different subcellular destinations. 
 Proteins of the GRASP (Golgi reassembly stacking 
protein) and golgin families are part of the structural 
organization of the Golgi apparatus.[2,3] Two proteins 
involved in mammalian Golgi stacking and laterally linking 
the Golgi cisternae to form Golgi ribbons are GRASP65 and 
GRASP55.[4,5] GRASP55, anchored to the medial Golgi 
membrane by myristoyl and palmitoyl groups, interacts 
with the golgin protein Golgin-45.[6] GRASP65, differing in 
localization, is N-terminally associated with the membranes 
of the cis Golgi through a myristoyl group. Interaction with 
the C-terminus of the Golgi marker protein GM130 recruits 
GRASP65 to the cis-Golgi membrane where it is involved in 
the docking of transport vesicles to the Golgi 
membrane.[5,7,8] 
 The human GRASP65 (hGRASP65) protein contains 
two PDZ domains (PDZ1, PDZ2) at the N-terminus, which, 
together, represent the entire GRASP domain (Figure 1A). 
The PDZ domains of GRASP65, especially the PDZ1 domain, 
are known to be essential for self-association of the protein 
and for initiating the linking of Golgi cisternae into mini 
stacks.[9–11] Initial biochemical studies suggested that the 
binding motif for GM130 is found within the second PDZ 
domain of GRASP65, but recent crystallographic studies of 
A 
 
 
 
256 C. M. JURK et al.: Crystal Structures of the Single PDZ Domains from GRASP65 
 
Croat. Chem. Acta 2018, 91(2), 255–264 DOI: 10.5562/cca3341 
 
 
 
the hGRASP65 GRASP domain bound to the C-terminal tail 
of GM130 showed that both PDZ domains are involved in 
GM130 binding.[12] The C-terminal region of GRASP65 
consists of an SPR (serine/proline rich) domain which is a 
target for multiple phosphorylation during mitosis.[13]  
 PDZ domains comprise 80-100 residues and are 
often found in multi-domain proteins used as scaffolds, 
especially in signal transduction complexes. PDZ domains 
were initially characterized in the post-synaptic density 
protein PSD95, the Drosophila disc large tumor suppressor 
(Dlg1) and zona occludens-1 protein (ZO-1), and their name 
is derived from these three proteins. Almost all PDZ 
domains share a β-sandwich fold containing six β-strands 
framed by two α-helices.[14,15] A common feature of PDZ 
 
Figure 1. Domain architecture and PDZ structures of GRASP65. (A) Domain organization and boundaries of GRASP65. The two 
N-terminal PDZ domains are shown in dark gray and the C-terminal serine/proline-rich domain (SPR) in light gray. The two PDZ 
domains, residues 1-204, comprise the GRASP domain, which is anchored to the Golgi membrane via its myristoylated N-
terminal glycine (G2myr). The crystal structure of monomeric GRASP65PDZ1 is shown in (B) and of GRASP65PDZ2 in (C). The cartoon 
representations are color-coded from the N-terminus in blue to the C-terminus in red. Non-resolved amino acids are indicated 
by a dashed line. The electrostatic surface representations for GRASP65PDZ1 (D) and GRASP65PDZ2 (E) are shown in the same 
orientation as the structures above and were calculated by the Adaptive Poisson-Boltzmann Solver implemented in the Pymol 
software.[41] Blue indicates positive charge and red negative charge at the level of ± 5 kT/e. 
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domains is their ability to bind the C-terminus of protein 
ligands in a hydrophobic binding pocket in addition to the 
binding by a highly conserved carboxylate-binding loop, 
which is also involved in the binding of non-peptide 
inhibitors.[16] Binding of internal sequences in the peptide-
binding pocket has also been reported.[15,17]  
 To understand the binding of GM130 by GRASP65 in 
more detail, we studied GRASP65 binding of GM130 
derived peptides by isothermal titration calorimetry (ITC) in 
conjunction with structural analysis. For these studies, we 
used different GRASP65 constructs, comprising the 
individual PDZ domains, the entire GRASP domain or an N-
terminally truncated GRASP domain. We present here the 
crystal structures of the single PDZ domains of GRASP65 as 
well the first PDZ domain structure of the GRASP65 yeast 
homolog, Grh1. 
 
MATERIALS AND METHODS 
Protein Expression and Purification 
Fragments of the human grasp65 gene (gene ID: 64689) 
encoding amino acid residues (aa) 1-118 (GRASP65PDZ1), aa 
108-204 (GRASP65PDZ2) and aa 1-204 (GRASP651-204), and of 
the Saccharomyces cerevisiae gene grh1 (gene ID: 852129) 
encoding the fragment aa 67-144 (GRH1PDZ1Δβ) were 
inserted into a pET-46 Ek/LIC vector using the ligation 
independent cloning (LIC) technique[18] according to the 
manufacturer’s instructions (Novagen). Additionally, a 
PreScission protease recognition sequence (LEVLFQGP) was 
introduced at the 5’-end of the construct. Template cDNA 
of human grasp65 was kindly provided by Erich Wanker 
(MDC Berlin-Buch, Germany). Yeast cDNA, used as a 
template, was kindly provided by Thomas Sommer (MDC 
Berlin-Buch, Germany).  
 For recombinant protein expression, E. coli T7 
Express Rosetta 2 cells (New England Biolabs) were 
transformed with the pET-46 Ek/LIC plasmid harboring the 
grasp65 or grh1 constructs. All constructs were expressed 
as fusion proteins with an N-terminal His6 tag. Cells were 
grown in Superior Broth (SB) medium supplemented with 
the appropriate antibiotics at 37 °C to an OD600 (optical 
density at 600 nm) of 1. Cells were then cooled down to 20 
°C, and gene expression was induced with 1 mM isopropyl-
β-D-thiogalactopyranoside (IPTG). 16 h after induction, 
cells were harvested, resuspended in lysis buffer (20 mM 
HEPES, pH 8.0, 500 mM NaCl, 10% glycerol, 10 mM 
imidazole) and lysed with a Sonoplus sonifier (BANDELIN 
electronic). 
 Proteins were purified by affinity chromatography 
with an Äkta (GE Healthcare) purification system using a 
HisTrapTM FF (GE Healthcare) column. After the wash step 
(20 mM HEPES, pH 8.0, 500 mM NaCl, 40 mM imidazole), 
protein was eluted with 250 mM imidazole and incubated 
with PreScission protease to cleave off the His6 tag 
overnight while dialyzing against a 100 fold excess of 20 
mM HEPES, pH 8.0, 250 mM NaCl and 2 mM β-mercapto-
ethanol. For tag and protease removal, a second affinity 
chromatography step was used. Finally, size exclusion 
chromatography on a HiLoad 26/60 Superdex 75 gel 
filtration column (GE Healthcare) was performed in a buffer 
containing 20 mM HEPES, pH 8.0, 250 mM NaCl, 1 mM 
EDTA and 2 mM 2-mercaptoethanol. Peak fractions were 
concentrated to 10-15 mg/ml. In contrast to the GRASP65 
constructs, the tag was not removed for Grh1PDZ1Δβ due to 
subsequent protein instability. Site-directed mutagenesis 
was performed using the QuikChange®Site-Directed 
Mutagenesis Kit (Stratagene, USA) according to the manu-
facturer’s instructions. 
Crystallization 
Crystals were grown by vapor diffusion using the sitting 
drop method with a semi-automated dispensing system 
(Hydra II, Matrix). GRASP65PDZ1 crystals were obtained 
within 24 h in 24% PEG1500 and 20% glycerol at 20 °C. 
GRASP65PDZ2 crystals appeared in 2-3 weeks in a condition 
containing 1.4 M Na/K phosphate, pH 8.2, also at 20 °C. 
Grh1PDZ1Δβ crystals were obtained within 3-4 weeks in 3.0 M 
NaCl and 100 mM Bis-Tris, pH 5.5 at 20 °C. The best crystals 
of GRASP65PDZ2 and Grh1PDZ1Δβ were flash frozen in mother 
liquor containing 20% PEG400 or 20% glycerol, res-
pectively. 
Data Collection and Structure 
Determination 
Diffraction data were collected at a temperature of 100 K 
at beamline 14.1 at BESSY II (Helmholtz-Zentrum Berlin, 
HZB) in Germany.[19] GRASP65PDZ1 data from a crystal in 
space group C2221 containing one protein molecule per 
asymmetric unit (AU) were collected at 100 K to a 
resolution of 2.7 Å, and GRASP65PDZ2 data were obtained up 
to 2.1 Å resolution from a space group C2 crystal with two 
protein molecules per asymmetric unit. Data were 
processed using XDS.[20,21] Phases were obtained by 
molecular replacement with Phaser[22] from the CCP4 
suite[23,24] using the coordinates of the matching GRASP55 
PDZ domain (PDB entry code: 3RLE) as search model. 
Subsequently, an atomic model was built and refined using 
COOT and REFMAC5.[25–28]  
 A 1.4 Å native dataset was collected at a wavelength 
of 0.91841 Å from a Grh1PDZ1Δβ crystal at beamline MX14.2 
at BESSY. Additionally, a 1.75 Å data set collected at 
1.77122 Å from a crystal obtained under the same 
crystallization condition was used for an S-SAD experiment. 
Both data sets were processed using XDS, with the keyword 
‘FRIEDEL’S_LAW=FALSE’ for the 1.75 Å data set.[20,21] Both 
crystals belonged to space group P3121. Based on the 
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anomalous scattering from three sulfur atoms present in 
two methionine residues and one cysteine residue, we 
could solve the phase problem by using the S-SAD 
method[29,30] of Auto-Rickshaw, an automated crystal struc-
ture determination platform.[31] The polypeptide backbone 
could be traced automatically by ARP/wARP.[32] Subseq-
uently, an atomic model was built and refined against the 
native dataset using COOT[25,26] and REFMAC5.[27,28]  
 All data collection and refinement statistics are given 
in Table 1. The final structures were validated using 
MolProbity.[33] The atomic coordinates and structure 
factors for GRASP65PDZ1 (code 6G8T), GRASP65PDZ2 (code 
6G8W) and Grh1PDZ1Δβ (code 6G8Y) have been deposited in 
the Protein Data Bank (http://wwpdb.org/). 
Isothermal Titration Calorimetry (ITC) 
For ITC measurements, different GRASP65 constructs 
comprising the entire GRASP domain (aa 1-204) and the 
single PDZ domains were prepared as described above. 
Peptides of the C-terminus of GM130 were purchased in 
lengths of six and twelve amino acids from Peptide 
Specialty Laboratories (PSL, Heidelberg). To avoid any 
buffer mismatch between protein and peptide, all 
constructs and peptides were extensively dialyzed (20 mM 
HEPES, pH 8.0, 250 mM NaCl). Prior to the ITC 
measurements the samples were degassed under vacuum 
with stirring using a ThermoVac (Microcal). The ITC 
measurements were run in a VP-ITC micro calorimeter 
(Microcal). The cell was loaded with 2 ml of 75 µM protein 
Table 1. Data collection and refinement statistics 
 GRASP65PDZ1 GRASP65PDZ2 Native Grh1PDZ1Δβ S-SAD Grh1PDZ1Δβ 
Data collection 
Wavelength 
 
0.91841 
 
0.91841 
 
0.91841 
 
1.77122 
Space group C2221 C2 P3121 P3121 
Cell dimensions     
  a, b, c (Å) 46.4, 63.2, 80.8 50.8, 82.6, 49.2 53.4, 53.4, 50.9 53.5, 53.5, 51.0 
  α, ϐ, γ (°)  90.0, 90.0, 90.0 90.0, 110.8, 90.0 90.0, 90.0, 120.0 90.0, 90.0, 120.0 
Resolution (Å)* 33.93–2.67  
(2.74–2.67) 
26.85–2.12  
(2.18–2.12) 
26.72–1.40 
(1.50–1.40) 
34.28–1.75 
(1.84–1.75) 
Rmeas(a) (%)* 6.2 (75.5) 7.8 (62.8) 4.2 (61.5) 5.3 (70.5) 
Average I/σ (I)* 20.7 (2.3) 15.8 (3.0) 22.96 (3.4) 36.55 (3.2) 
Completeness (%)* 99.8 (100.0) 99.3 (100.0) 99.7 (99.6) 98.9 (93.6) 
Multiplicity 4.3 4.1 6.5 15.2 
     
Refinement     
No. reflections 3394 10222 16072  
Rwork(b)/ Rfree(c) (%) 20.9/25.8 18.6/23.5 16.3/21.0  
No. atoms     
Protein 848 1378 801  
Ligands 1 5 3  
Water 9 96 141  
B-factors     
Overall mean (Å2) 62.1 32.9 25.0  
R.m.s. deviation     
Bond lengths (Å)  0.007 0.020 0.010  
Bond angles (º) 
Ramachandran map 
Most favored (%) 
Additionally allowed 
Disallowed (%) 
1.25 
 
97.12 
2.88 
0.00 
1.97 
 
94.74 
5.26 
0.00 
1.45 
 
100.00 
0.00 
0.00 
 
* Values in parentheses refer to outer resolution shell. 
(a) Rmeas = redundancy-independent Rmerge, Rmerge=∑hkl∑i│Ii(hkl)-<I(hkl)>│/∑hkl∑iIi<(hkl)>, sum i is over all separate measurements of unique reflection hkl. 
(b) Rwork=∑hkl││Fobs│-│Fcalc││/∑hkl│Fobs│. 
(c) Rfree as Rwork, but summed over a 5% test of randomly chosen reflections. 
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solution, and 1.5 mM peptide solution was placed in the 
syringe. About 60 injections were performed with a volume 
of 2.5 µl for the first and 5 µl for the remaining injections. 
Time between injections was 240 s. All experiments were 
conducted at 15 °C with a stirring speed of 307 rpm. Raw 
data were baseline fitted with NITPIC (version 1.2.2)[34] and 
integrated using ORIGIN (version 7.0, OriginLab). 
 
RESULTS 
Structures of the Single PDZ Domains of 
GRASP65 
The first PDZ domain of the GRASP domain comprises 
amino acid residuess 1-104 (Figure 1A). The N-terminal 
amino acids 1-12 in the crystallized GRASP65PDZ1 construct 
were not explained by electron density and could not been 
modeled. The globular structure, as shown in Figure 1B, 
consists of six β-strands (βA-βF) and three α-helices (αA, αB 
and αL) arranged in a partially opened β-sandwich typical 
of PDZ domains. Helix αL represents the linker connecting 
the first with the second PDZ domain of GRASP65. The 
structure exhibits, as other PDZ domains do, a ligand-
binding pocket formed by strand βB and helix αB, exposing 
positively charged residues (Figure 1D). 
 The second PDZ domain, GRASP65PDZ2, was also 
crystallized (Figure 1C) and also exhibited the typical PDZ fold 
consisting of five β-strands (βA-βD and βF) and two α-helices 
(αA and αB). In contrast to PDZ1, here the ligand-binding 
pocket shows a more hydrophobic character (Figure 1E).  
 As shown in the superposition of GRASP65PDZ1 and 
GRASP65PDZ2 (Figure 2A) both domains reveal a similar 
structure with an elongated carboxylate-binding loop 
between strands βA and βB. The Cα atom r.m.s. deviation 
is 0.78 Å (calculated with PyMOL, DeLano Scientific, USA) 
despite a low sequence match of 35 %, shown by the 
sequence alignment (Figure 2B). 
Dimerization of the Single GRASP65 PDZ 
Domains 
Crystal structures of both monomeric PDZ domains of 
GRASP65 are illustrated in Figure 1. Size-exclusion 
chromatography, however, reveals formation of mainly 
tetramers for GRASP65PDZ1 and dimers for GRASP65PDZ2 in 
solution (Figure 3A, B). Insight into the geometry of the 
arrangements may be obtained from the crystal packing. In 
both crystal structures, two protein molecules are forming 
a dimer via the peptide binding pocket. In GRASP65PDZ1, 
which crystallized in space group C2221 with one protein 
molecule per AU, the dimer is formed via the twofold axis 
along the crystallographic b axis. A tetrameric arrangement 
as observed in solution could not be found in the 
GRASP65PDZ1 crystal. The two molecules per AU, present in 
the space group C2 crystals of GRASP65PDZ2, form a dimer 
via non-crystallographic symmetry (NCS). In both structures 
the C-terminus of molecule 1 form hydrogen bonds with 
the carboxylate binding loop of molecule 2, thus mimicking 
the classical PDZ-ligand interaction. For GRASP65PDZ1 the C-
terminal carboxylate group of Val118 of molecule 2 (Figure 
3C) forms four hydrogen bonds with the backbone of 
residues Leu95, Leu96, Gly97 and Ala98 in the carboxylate 
binding loop of molecule 1. An additional hydrogen bond is 
formed with the carbonyl oxygen of Ala98 and the 
backbone nitrogen of Val118 (Figure 3C).  
 In GRASP65PDZ2 the carboxylate group of the C-
terminal residue Thr204 of molecule 2 also forms four 
hydrogen bonds with the backbone of residues Ser189, 
Leu190, Gly191 and Cys192 of molecule 1 with an extra 
hydrogen bond between the carbonyl oxygen of Cys192 
and the backbone nitrogen of Thr204 (Figure 3D). 
 With 1027 Å², the dimer interface of GRASP65PDZ1 
covers 9.5% of the total solvent-accessible surface (SAS) of 
both subunits (10850 Å²). The dimer interface of 
 
Figure 2. Superposition of GRASP65PDZ1 and GRASP65PDZ2. (A) 
Structure of GRASP65PDZ1 (green) is superimposed onto 
GRASP65PDZ2 (blue) with an r.m.s.d. of 0.78 Å. (B) Sequence 
alignment of PDZ1 and PDZ2 of GRASP65 (with ESPript 
2.2).[42] 
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GRASP65PDZ2 covers 8.5% of the SAS (832 Å² of 9800 Å² in 
total) as calculated using PDBe PISA.[35] 
Interaction of the GRASP Domain with 
GM130 
In order to analyze the binding of GRASP65 to the golgin 
GM130 in greater detail, different GRASP65 constructs were 
prepared comprising either the entire GRASP domain 
(GRASP651-204) or the single PDZ domains (GRASP65PDZ1 and 
GRASP65PDZ2). The single PDZ domains and GRASP651-204 
were titrated in the ITC experiment with the hexapeptide 
NVKITVIC representing the C terminus of GM130. A dodeca-
meric GM130 peptide (NADENDEVKITVIC) was only titrated to 
GRASP651-204. GRASP65PDZ2 alone showed no binding of 
 
Figure 3. Oligomerization of the single GRASP65 PDZ domains. (A) Elution profile of GRASP65PDZ1 shows a main peak in size 
exclusion chromatography at ~ 50 kDa, which corresponds to a tetramer size of GRASP65PDZ1 (molecular mass of monomer is 
13 kDa). A small portion of higher oligomers is visible at ~80-90 kDa. (B) The elution profile of GRASP65PDZ2 shows a peak at ~20 
kDa, which indicates dimer formation. The size of the molecular weight standards is given above the elution profiles. Protein 
dimers are found in crystals of GRASP65PDZ1 (C) and of GRASP65PDZ2 (D). The packing of the two molecules in the crystal is shown 
on the left. Molecule 1 is color-coded from the N-terminus (blue) to the C-terminus (red). Molecule 2 is depicted in gray. The 
ligand-binding pocket is shown in detail in the magnified inset. Residues contributing in the dimer formation are shown as stick 
model with surrounding 2Fo−Fc electron density contoured at 1 sigma. Hydrogen bonds are represented as dashed lines. 
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VKITVI (Figure 4B), whereas GRASP65PDZ1 did, indeed, show 
binding of the hexapeptide (Figure 4A). The ITC data could 
only be fitted by using a 4-site sequential binding model, indi-
cating that four peptides associate with GRASP65PDZ1. Due to 
our observation that the isolated PDZ1 domain of GRASP65 
elutes as tetramer in size exclusion chromatography, we as-
sume that the binding of the peptide may cause a dissocia-
tion of the tetramer, possibly triggered by conformational 
changes in the subunits of the multimeric protein. Therefore 
we could only fit the data to a sequential binding model with 
a resulting overall dissociation constant of KD = 41.8 ± 3.0 μM. 
It is not possible to obtain a dissociation constant for each 
binding site for this sequential binding site model, because 
all possible states of association exist in equilibrium. The 
titration of the VKITVI hexapeptide to the construct 
GRASP651-204 revealed a KD of 25.1 ± 0.6 µM (Figure 4C). The 
GM130 dodecapeptide ADENDEVKITVI showed binding of 
the entire GRASP domain (GRASP651-204) with a KD of 27.6 ± 
0.6 μM (Figure 4D). In both cases, the binding stoichiometries 
(N values) differ from 1:1 and are difficult to explain. In the 
absence of other evidence, we cannot exclude the possibility 
that the complex stoichiometries reflect incomplete binding 
of the ligand peptides to protein domains whose binding 
sites are partially occupied by terminal peptides from other 
protein chains, in a similar way as seen in the crystals. 
Crystal Structure of Grh1, the Yeast 
Homolog of GRASP65 
In addition to the GRASP65 PDZ domain structures, the 
structure of the first PDZ domain,  Grh1PDZ1ΔβB (aa 67-144), 
of the GRASP65 yeast homolog Grh1[36,37] was determined 
using the sulfur SAD method.[25,26] The first PDZ domain of 
Grh1 consists of four β-strands (βA, βC, βD and βF), three 
α-helices (αA, αB and αP) and an extended loop region 
connecting strand βD with helix αB (Figure 5A). Although 
the crystallized fragment lacks the carboxylate-binding loop 
and the central strand βB, the structure exhibits a PDZ-like 
fold. These two C-terminal structural elements were 
omitted from the cloned construct due to issues of low 
solubility or low level of overexpression encountered with 
longer protein constructs. This becomes obvious in the 
superposition of GRASP65PDZ1 and Grh1PDZ1ΔβB (Figure 5B). 
In spite of the very low sequence identity of 10%, the PDZ 
structures superimpose quite well (r.m.s.d. = 1.4 Å for Cα 
atoms) (Figure 5C). That proves that similar PDZ folds can 
be adopted by sequentially distant protein domains. 
 
DISCUSSION 
We present the crystal structures of the two separate PDZ 
domains of human GRASP65, GRASP65PDZ1 and 
GRASP65PDZ2. Notably, both structures reveal a variation of 
the canonical PDZ fold, which is reflected in the sequential 
order of the secondary structure elements. As already 
shown for GRASP55,[38] also GRASP65 contains two 
circularly permuted PDZ domains revealing the secondary 
structure organization βαβαβββ typical of bacterial PDZ-
like domains instead of the βββαββαβ pattern normally 
found in mammals, such as human PSD-95.[14] We observed 
this βαβαβββ permutation also in Grh1, the yeast homolog 
 
 
Figure 4. Titration of GRASP65 constructs with the GM130 peptides NVKITVIC and NADENDEVKITVIC.  (A) GRASP65PDZ1 titration 
with NVKITVIC peptide. The data were fitted to a sequential binding site model with 4 binding sites and revealed a KD = 41.8 ± 
2.97 μM, ΔH = -369.9 ± 12.0 cal/mol, ΔS = 18.7 cal/mol/deg. (B) The GRASP65PDZ2 titration with NVKITVIC GM130 peptide did 
not show any binding. (C, D) The titration of the GRASP domain (GRASP651-204) is shown with GM130 NVKITVIC peptide in C) and 
NADENDEVKITVIC in D). The following thermodynamic parameters were determined for (C) KD = 25.06 ± 0.63 μM, ΔH = -6427 ± 
120.3 cal/mol, ΔS = -1.25 cal/mol/deg and N = 0.46 sites; for (D) KD = 27.62 ± 0.59 μM, ΔH = -4160 ± 212.4 cal/mol, ΔS = 6.43 
cal/mol/deg and N = 0.17 sites. 
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of GRASP65, but in slightly incomplete form lacking the last 
β strand. Despite very low sequence identity of only 10%, 
Grh1PDZ1ΔβB also shows a PDZ folding pattern indicating 
structural conservation that is not reflected in the amino 
acid sequence. Circular permutations of protein sequences 
are frequently observed and may occur in different protein 
folds.[39,40] 
 To characterize the binding of GM130 to GRASP65 in 
detail, we used the isothermal titration calorimetry 
method. Instead of in vitro translated protein constructs or 
GST-tagged GM130 fragments,[8,13] we used untagged 
GM130 peptides for the ITC measurements and combined 
them with various recombinantly expressed GRASP65 
constructs using either the single PDZ domains or the entire 
GRASP domain. In contrast to earlier observations[13] we 
could not verify that GRASP65PDZ2 alone is sufficient for 
GM130 binding. The same observation was recently made 
by Hu et al. who showed that only the GRASP65 PDZ1 and 
PDZ2 in tandem are capable of GM130 binding, where the 
first PDZ domain is the key player in this molecular 
interaction.[12] Our own ITC experiment reveals a peptide 
length of six amino acids (VKITVI) of the GM130 C-terminus 
for sufficient binding to the isolated first PDZ domain and 
to the entire GRASP domain GRASP1-204, but not to the 
isolated second PDZ domain of GRASP65. The GM130 
dodecapeptide ADENDEVKITVI bound to the entire GRASP 
domain with a KD of 27.6 μM, i.e. with a similar affinity as 
observed with the GM130 hexapeptide (KD=25.2 μM). That 
indicates that the additional amino acids more distant from 
the C terminus of GM130 do not significantly contribute in 
binding to the GRASP domain. These additional residues 
form an exposed loop and are not involved in binding to 
 
Figure 5. Crystal structure of Grh1PDZ1Δβ compared to GRASP65PDZ1. (A) Cartoon representation of the monomeric Grh1PDZ1Δβ 
structure, color-coded from the N-terminus in blue to the C-terminus in red. Helix αP belongs to the Prescission protease 
recognition site. The construct consists of four β-strands (βA, βC, βD and βF), three α-helices (αA, αB and αP) and an extended 
loop region connecting strand βD with helix αB. The uncleaved His6 tag was not visible in the electron density. (B) Superposition 
of GRASP65PDZ1 and Grh1PDZ1Δβ. The structure of GRASP65PDZ1 is shown in green. The structure of Grh1PDZ1Δβ is displayed in red. 
The black arrow shows the putative position of the missing strand βB of Grh1PDZ1Δβ guided by the position of βB from 
GRASP65PDZ1. The dashed line indicates the approximate position of the missing carboxylate-binding loop and the C-terminus 
completing the PDZ of Grh1. For reasons of clarity the N-terminal helices αL from GRASP65PDZ1 and αP from Grh167-114 are not 
shown. (C) Sequence alignment of both PDZ domains comprising residues 13-105 for GRASP65PDZ1 and 69-144 for Grh1PDZ1Δβ as 
shown in the structure in (B). 
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GRASP65 as observed in the crystal structure of Hu et al.[12] 
There, a 22-residue peptide NSNPCIPFFYRADENDEVKITVIC is 
bound to the GRASP domain with a KD of 108 nM. This 230 
times lower KD as compared to the hexa- and 
dodecapeptides examined in the current study is likely to 
result from additional hydrophobic residues present in the 
longer peptide, which are binding into the strongly 
hydrophobic inter-domain pocket of the GRASP domain. 
Our measured KD reflects the contribution of the 
conventional PDZ domain recognition mode to the overall 
GM130-GRASP65 interaction. 
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